Cannabis Canada Association, collectively, represents the majority of Licensed Producers of cannabis for medical purposes as licensed and regulated by the Office of Medical Cannabis and the Controlled Substance and Tobacco Branch, under the Health Canada’s Marijuana for Medical Purposes Regulations (MMPR), in force as of April 1, 2014, recently modified on August 24, 2016 and renamed Access to Cannabis for Medical Purposes Regulations (ACMPR).
Our members have been working in the area of medical cannabis for many years. During this time, significant knowledge and expertise in the field of medical cannabis has been developed within the Association. First and foremost our commitment is to our patients. We are able to serve the needs of our patients, work with key stakeholders, and grow the industry to meet the demand for safe product across the country.
Cannabis Canada Association’s mission is to act as the national voice for our members in their promotion of industry standards, and support the development, growth and integrity of the regulated cannabis industry. The Association serves as a trusted resource on issues related to the safe and responsible use of cannabis for medical and non-medical purposes. The Association shares a philosophy of both patient-centric care and improved public health, and is committed to product safety and quality, secure and reliable access and the promotion of the safe and effective use of cannabis.
Our Commitment to Members
Cannabis Canada Association provides advice on key areas and issues that will impact all Licensed Producers
- access, production, delivery and use models
- regulations for medical use
- regulations for consumer use
Cannabis Canada builds the organization to better serve our members. Cannabis Canada is a trusted resource for:
- patients, consumers, public health and public safety
- our allies and partners
- educational initiatives for stakeholders and the general public
Our Commitment to Patients
Our members have significant knowledge and expertise in the therapeutic use of medical cannabis. We share a philosophy of patient-centred care and improved public health, and are committed to product safety and quality, secure and reliable access for qualified patients, and promotion of the safe and effective use of medical cannabis.
Our Commitment to the Community
We are committed to working collaboratively with our patients, government, educational institutions, health care providers and law enforcement agencies on issues related to the access and regulation of cannabis.
Cannabis Canada Association is committed to conducting its activities with integrity and in accordance with the highest ethical standards. Cannabis Canada Association Board of Directors, as voting members, conducts business through regular meetings of the full Board as well as those of the Committee on Regulations, the Communications Standard Committee and the Patients Committee. The Board of Directors ensures that all activities conducted by Cannabis Canada Association are in full compliance with the terms of the Association, respecting the Health Canada ACMPR guidelines. Currently, eight Cannabis Canada Association members/licensed producers, including the Chairman (elected by Cannabis Canada Association members),Vice-Chairman and Treasurer sit on the Board of Directors. The Executive Director sits as the Secretary. Elections for the Board of Directors take place annually at Cannabis Canada Association Annual General Meeting. All other committee membership is open to only Cannabis Canada Association Full Members (Licensed Producers). Please make any governance enquiries to: firstname.lastname@example.org.
Board of Directors
- Neil Closner, MedReleaf (Chair)
- John Aird, Aphria
- Cam Battley, Aurora
- Avtar Dhillon, Emerald Health Biologicals
- John Fowler, 7 ACRES
- Sébastien St. Louis, Hydropothecary
- John Stewart, Emblem Cannabis.
- Ashleigh Brown
- Joseph Gallis, Loeys-Dietz Syndrome Canada
- Mandy McKnight
- Carole Reece, Canadian Arthritis Patient Alliance
- Jonathan Zaid, Canadians for Fair Access to Medical Maijuana
Committee on Regulations
- Chris Stone, Broken Coast (Chair)
- Olga Janek, Aphria
- Penny Sterling, Aurora
- Pedro Jorge, Bonify
- Michael Bierman, Emerald Health Botanicals
- Shane Morris, Hydropothecary
- Andrea Park, MedReleaf
- Sonya Richard, Organigram
- Jennifer Maccarone, Up Cannabis.
All Licensed Producers under the ACMPR by Health Canada, who are authorized to produce and/or sell to the public, are eligible to become Full Members.
We are also accepting applications for General Membership.